Silicon Labs Unveils the Next Evolution of IoT Development with the Simplicity Ecosystem

Developers gain faster, smarter workflows today – and AI-powered collaboration in 2026 Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, today announced the launch of the Simplicity Ecosystem, a next-generation suite of modular software tools with planned AI augmentation designed to transform embedded IoT development. Anchored by Simplicity Studio 6 and complemented by […]

ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II Development of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II Development of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections GlobeNewswire October 22, 2025 MELBOURNE, Australia, Oct. 22, 2025 (GLOBE NEWSWIRE) — ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense enhancers to minimize the impact of symptomatic viral respiratory infections, announces

Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

(NasdaqGM:ANL), SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 22, 2025 (GLOBE NEWSWIRE) — Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will deliver an oral presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and

Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire October 22, 2025 SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 22, 2025 (GLOBE NEWSWIRE) — Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the

Citibank is Ranked No. 1 Among Banks in Singapore for Total Experience in Report by Independent Research Firm

Bank takes top spot in inaugural report combiningbrand and customer experience Citibank was ranked first out of six banks in the inaugural Singapore total customer experience score rankings, 2025 report by global research and advisory firm Forrester. https://mma.prnewswire.com/media/2405194/Citi_RGB_new_Logo.jpg The Total Experience Score is a composite of Forrester's Brand Experience (BX) Index and Customer Experience (CX)

Classic Never Fades. iCAUR Unveils New Brand Vision

(HKSE:9973.HK), WUHU, China, Oct. 21, 2025 (GLOBE NEWSWIRE) — On the afternoon of October 19, smooth jazz set the tone at the iCAUR (one of Chery Automobile's overseas brands) International User Summit. The brand opened a global session on Classic, Co-creating, and Innovation, welcoming over a hundred partners from around the world. Figure 1 From

Classic Never Fades. iCAUR Unveils New Brand Vision

Classic Never Fades. iCAUR Unveils New Brand Vision GlobeNewswire October 22, 2025 WUHU, China, Oct. 21, 2025 (GLOBE NEWSWIRE) — On the afternoon of October 19, smooth jazz set the tone at the iCAUR (one of Chery Automobile's overseas brands) International User Summit. The brand opened a global session on Classic, Co-creating, and Innovation, welcoming

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock

(NasdaqGM:RAPT), SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced the pricing of an underwritten public offering of 8,333,334 shares of its common stock at

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock GlobeNewswire October 22, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced the pricing

Scroll to Top